-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 17, Kangtai Biologics issued an announcement stating that the oral five-valent reassortant rotavirus live attenuated vaccine (Vero cells) developed by it and its wholly-owned subsidiary Minhai Biotechnology recently obtained the "Clinical Medicines" issued by the National Medical Products Administration.
Test Approval Notice
.
The vaccine is used to prevent infantile diarrhea caused by rotavirus infection in infants and young children 6 weeks of age and older